Design, Operation and Management of GTP/GMP Cell Engineering Facilities
|
|
|
- Christiana Irene Horton
- 9 years ago
- Views:
Transcription
1 Design, Operation and Management of GTP/GMP Cell Engineering Facilities Scott R. Burger, MD Advanced Cell & Gene Therapy BFDA 2007 International Symposium on Regulation of Human Cell and Tissue- Based Products Taipei, Taiwan October 3, 2007
2 HCT/P Manufacturing Facilities Roles of the GTP facility and the GTP/GMP facility GTP facility Lower risk, basic cell therapy products, minimal manipulation. GTP/GMP facility Higher risk, more complex cell therapy products, more-than-minimal manipulation. More control needed.
3 GTP Facility Lower-risk, minimally manipulated products, such as cryopreserved autologous peripheral blood progenitor cells No requirement for cleanroom, but GTP systems needed Organization, personnel Facilities, monitoring Equipment, supplies and reagents Quality program Procedures Process validation, controls, changes Storage, receipt, distribution Tracking Labeling controls, records, complaint file Cytotherapy : Cell & Gene Therapy :16-22
4 Quality Program GTP Elements Organization and Personnel Procedures Facilities Environmental Control, Monitoring Equipment Supplies and Reagents Process Controls Process Changes Process Validation Labeling Controls Storage Receipt and Distribution Records Tracking Complaint File Specifics Formal quality program, all aspects of operations, assure GTP compliance Personnel qualification, training SOPs for all significant manufacturing steps, authorization of deviations Facility and equipment operations, cleaning, validation Equipment and environmental monitoring Requirements, qualification, control of materials Validation, control of manufacturing processes, process modifications. Corrective action plan. Controlled product labeling, prevention of mix-ups Provisions for raw material, product storage Record keeping, data management Tracking from donor-recipient, recipient-donor Outcome analysis, deviation tracking, AE reporting
5 GTP Facility - Quality Program Required under GTPs Address communicable disease risks Specific for types of products manufactured Cover core GTPs Establish and maintain procedures related to core GTPs Receive, investigate, evaluate and document information relevant to core GTPs
6 GMP Facility Higher-risk, more complex cell therapy products ( 351 HCT/Ps) Cleanroom facility, with GMP systems in place Organization, personnel, training, evaluation Buildings and facilities Equipment, reagents and supplies Procedures Production and process controls Finished product control Laboratory controls Records and reports Cytotherapy : Cell & Gene Therapy :16-22
7 Quality Assurance (QA) Oversight responsibilities Process of monitoring a study to assure management that the facilities, equipment, personnel, methods, practices, records and controls are in accordance with applicable regulations. Auditing methods, results, systems and processes. Separate from Quality Control. QA must maintain independence, and so should notreporttomanufacturing. 7
8 Quality Control (QC) Responsible for accepting or rejecting: Components, in-process material and product Procedures and specifications Review manufacturing records prior to release Laboratory facilities to perform testing Separate from Manufacturing staff
9 Documentation/Record-keeping Batch Production Records (BPRs) Fundamental GMP process documents, include manufacturing process, cleaning, etc. Standard Operating Procedures (SOPs) Laboratory records Notebooks, training logs, etc. Distribution records Documents should be approved by Quality unit GMP facility records should allow traceability Who did what, and when?
10 Qualification, Validation Programs Process Cleaning Quality Control Assays Equipment Facility
11 Performance Qualification (PQ) Verifies system performance, tested under actual running conditions across anticipated working range Process (method) validation Consistency of process, evidence of control Evaluate performance effects Ongoing monitoring
12 Monitoring Environmental, Personnel Baseline monitoring, trend analysis Particle counts, CFUs, microbial identification Airborne, surfaces Test under dynamic and static conditions Action/alert limits based on process, products, consequences Alert Limit Investigation Action Limit Corrective action
13 Equipment Qualification, validation IQ, OQ, PQ Equipment maintenance system Tracking Scheduled calibration, preventive maintenance Monitoring Incubators, LN 2 tanks, freezers, refrigerators Temperature, CO 2 concentration, humidity, other Establish acceptable/alarm ranges Monitoring data Archive data -- WORM drive, other Review data regularly, maintain review records
14 GMP Facility Separate/Defined Areas Materials management, storage Unqualified raw material Rejected materials Released raw materials storage In-process materials storage Manufacturing and processing operations Aseptic processing Packaging and labeling Product storage Quarantine, pre-release Released product Control and laboratory operations Controlled, limited access overall
15 Aseptic Processing Area (21 CFR ) HEPA-filtered air supply Temperature and humidity controls Environmental monitoring system Cleaning and sanitization system Equipment maintenance system FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing - Current Good Manufacturing Practice
16 Aseptic Processing Space Key Points Isolate individual products, prevent cross-contamination Unidirectional pathways personnel, raw materials, waste Entry Staging Process Exit Process room dimensions, access locations Gowning/degowning airlocks Consider doorway effects on room air quality, BSC air quality Facilitate cleaning and sterilization Smooth, non-porous, easily cleaned surfaces Movable furnishings, fixtures, avoid Clean-In-Place Externally-supplied resources LN 2, CO 2, other Limit sinks, drains
17 Aseptic Processing Personnel attire - full gowning, gloves, masks Air quality ISO 7/Class 10,000 or ISO 8/Class 100,000 Single-pass air for vector production Differential air pressure Positive pressure (purity) for transduction/expansion Negative pressure (containment) for vector production Processing in functionally-closed systems whenever possible Open process steps in ISO 5/Class 100 biological safety cabinet
18 Example Specifications - BL-2 Aseptic Processing Temperature 72 ± 2.5ºF Humidity 45 ± 5% Air velocity 60 ft/min ± 2% Air flow Air pressure Airborne particulates Airborne microbial contamination Surface microbial contamination Personnel Gowns Personnel Gloves room air changes per hour Positive pressure, 0.05 inches water between aseptic processing and other areas <100,000 measurable particles 0.5 mm diameter/ft 3 <1 CFU per 9-cm settling plate, 0.1 hr exposure <2 CFU/contact plate <40 CFU/contact plate <10 CFU/contact plate
19 GMP Facility Layout - Example Changing Room Process Room Process Room Engineering Changing Room Process Room Staging Room Staging Room Available Supplies Materials Management Positive Pressure Negative Pressure Process Room Process Room CO 2 LN 2 Cytotherapy 2000;2:111-22
20 EMO Biomedicine Facility Taipei Unclassified Space Support Corridor 無 塵 室 緩 衝 區 Clean Room II ISO 7/Class 10,000 ( 一 萬 級 ) Unclassified Space 無 塵 衣 更 換 區 Clean Room I ISO 8/Class 100,000 緩 衝 室 Gowning 動 線 方 向 + Pressure ( 十 萬 級 ) BSC 消 防 緊 急 出 口 人 員 出 入 口 開 放 實 驗 室
21 Cell Therapies Pty Melbourne, Australia Equipment QA Lab 1 2 Service 1 2 Legend 1. Gowning 2. Materials -General storage -Blood refrigerator, incubators -Pass-through hatch 3. Cleanroom -Biological safety cabinet -Centrifuge, incubators -Processing 4. Degowning Direction of Travel Documentation 3 4 3
22 MD Anderson Cancer Center Houston, Texas, USA
23 MD Anderson Cancer Center Houston, Texas, USA Minimal manipulation area One product per lab bay Shared equipment with appropriate segregation Quarantine areas for supplies, reagents, products Validated supply area, separate from GMP supplies
24 MD Anderson Cancer Center Houston, Texas, USA 11 ISO 7/Class 10,000 suites 7 Positive pressure 3 negative pressure 1 cell sorter Airlock/Gowning Unidirectional flow Entrance corridor Exit corridor Single-pass air
25 MD Anderson Cancer Center Houston, Texas, USA ISO 7/Class 10,000 cleanroom area Unidirectional flow of products, personnel, waste One protocol per suite Multiple patients per suite if appropriate segregation Quarantine areas for all supplies, reagents, products Validated supply area Each suite must be self-sufficient Pass-through boxes Manifold gas supply to all rooms
26 MD Anderson Cancer Center Houston, Texas, USA ISO 7/Class 10,000 cleanrooms Hard surfaces for ease of cleaning Seamless vinyl floors with integral coved base Hard ceiling in production suites, gasket ceilings elsewhere Stainless steel work surfaces No sinks/hands-free
27 Summary GTP and GMP/GTP cell therapy manufacturing facilities serve different roles in supporting clinical cell therapy. Multiuse cell therapy manufacturing facilities are most common, and must have robust segregation policies and procedures. Large GTP/GMP cleanroom facilities are impressive and glamorous, but very costly to build, and even more expensive to operate. Explore alternatives thoroughly before establishing a new facility!
28
29
30 Scott R. Burger, MD Advanced Cell & Gene Therapy +1 (919)
cgmp Challenges for Cord Blood Banks
cgmp Challenges for Cord Blood Banks Donna M. Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Cord Blood Bank processing facility challenges What does cgmp
Particle Monitoring Requirements in Pharmaceutical Cleanrooms
Particle Monitoring Requirements in Pharmaceutical Cleanrooms All drugs must be manufactured in accordance with the current Good Manufacturing Practice (cgmp) regulations. Pharmaceutical manufacturers
Environmental Monitoring of Clean Rooms
Environmental Monitoring of Raul Duarte President DDK Scientific, Corp. Copyright DDK Scientific, Corp. 2008, 2009, DDK Scientific, Corp. Proprietary A manufacturing facility for pharmaceutical products
International Standard ISO 14644
International Standard ISO 14644 Cleanrooms and associated controlled environments Praphon Angtrakool Food and Drug Administration 1 International Standard : ISO 14644 ISO 14644 consists of the following
MeriCal Quality Profile
January 5, 2015 Dear Valued Customer, Since the implementation of new federal regulations, MeriCal Inc. has received a large volume of questionnaires and surveys regarding our services and procedures.
Equipment Qualification
Equipment Qualification Deborah L. Griffin, BA Laboratory Supervisor, HSCLab Hillman Cancer Center University of Pittsburgh Cancer Institute University of Pittsburgh Medical Center Equipment Qualification
References to Computer and Software in FDA s CGTPs (Final Rule and Draft Guidance) for HCT/Ps Preamble to the CGTP Final Rule
Preamble to the CGTP Final Rule Pages 68626-68627 Computers Proposed 1271.160(e) would require establishments to validate computer software used as part of manufacturing or tracking or for maintaining
DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION
1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information
Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh
Production Records & Documentation Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh Production Records This Session: Production Records Basic Elements Regulatory
Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III
Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III BY DAVID W. VINCENT AND HERBERT MATHESON HEATING, VENTILATION, AND AIR CONDITIONING (HVAC) SYSTEMS INTRODUCTION
ENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORING Assessment and verification of the adequacy of the aseptic compounding environment is essential. Environmental monitoring programs are designed to promptly identify potential sources
Library Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
FDA and the Compounding Pharmacy
FDA and the Compounding Pharmacy Scott Sutton, Ph.D. [email protected] 41 Overview of Presentation The Recent Events GCP and GMP Basics the 483 Review H.R. 3204 Outsourcing Facility Preparation
Presented by Rosemarie Bell 24 April 2014
Global Good Manufacturing Practice A Comparability Study to Link Good Manufacturing Practice Standards for World Wide Compliance Within the Cellular Therapy Industry Presented by Rosemarie Bell 24 April
Manufacturing Cellular Products for International Clinical Trials
Manufacturing Cellular Products for International Clinical Trials Q U A L I T Y A N D O P E R A T I O N S T R A C K 7 4 / 2 5 / 1 4 1 3 : 4 5-1 5 : 1 5 Olive J Sturtevant, MHP,MT (ASCP)SBB, CQA Director
Guidance for Industry
Guidance for Industry Minimally Manipulated, Unrelated, Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution in Patients with Hematological Malignancies DRAFT GUIDANCE This
Facility Cleaning & Monitoring. Cleaning
Facility Cleaning & Monitoring Cleaning GTP Regulations: 21CFR Part 1271.190 Maintain facility in clean, sanitary & orderly manner Establish & maintain procedures for facility cleaning Assign responsibility
Manufacturing. Environmental Monitoring Particle Counts Are Easy B IOP ROCESSTECHNICAL. Scott E. Mackler
B IOP ROCESSTECHNICAL Environmental Monitoring Particle Counts Are Easy Scott E. Mackler Manufacturing pharmaceutical and biotechnology products requires that the appropriate level of quality be designed
Environmental Monitoring
Chapter 10 Environmental Monitoring By the end of this chapter, you will be able to: l List the types of environmental testing l Name three types of checks that are carried out to ensure the isolator is
CLEAN ROOM MONITORING REGULATORY STANDARDS
CLEAN ROOM MONITORING REGULATORY STANDARDS Air Classification as per Schedule M Maximum permitted number of particles / m3 equal or above at rest in operation 0.5µm 5.0µm 0.5µm 5.0µm A 3,520 29 3,500 29
Environmental Monitoring
Environmental Monitoring Purpose of Environmental Monitoring Critical process within the pharmaceutical and biotechnology industries. Determines the microbial and particulate content of cleanroom air and
*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV
WHO/VSQ/97.03 Original: English Distribution: General *XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV 3UHSDUHGE\*LOOLDQ&KDORQHU/DUVVRQ3K'*&/%LRFRQVXOW 2WWDZD&DQDGD /LQNWR&RQWHQWVSDJH GLOBAL PROGRAMME
Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE
Hazardous Drug. Cleanroom. Standards
Hazardous Drug Cleanroom Standards Module 3 Table of Contents Section A... 1 A.1 International Standards Organization (ISO) Classifications... 1 A.2 Hazardous Drug Cleanroom and Anteroom... 1 A.2.1 Location
Qualification of an Environmental Monitoring Program
[ Scott Sutton Qualification of an Environmental Monitoring Program Scott Sutton Microbiology Topics discusses various topics in microbiology of practical use in validation and compliance. We intend this
Everything you want to know about USP 797
Everything you want to know about USP 797 Dr. Linda D. Lee Director of Operations Waste Management Healthcare Solutions September. 22, 2009 Goals High level understanding of USP 797 Who does it apply too
AMENDED January 27, 2015
Proposed Language To Amend 1735 in Article 4.5 of Division 17 of Title 16 of the California Code of Regulations to read as follows: 1735. Compounding in Licensed Pharmacies. (a) Compounding means any of
Aseptic preparations, including TPN, for a limited number of patients
Aseptic preparations, including TPN, for a limited number of patients Group F (TPN) 1 Objective Presentation of our business case: setting up an aseptic TPN production in the Hilton Pharmacy instead of
GMP AUDIT CHECKLIST (AS PER WHO GUIDELINES) Page 1 of 32 INSPECTION OF:
GMP AUDIT CHECKLIST (AS PER WHO GUIDELINES) Page 1 of 32 Full Address of Company: Products manufactured Location of production Inspection type: mark all that apply external { } routine { } concise { }
DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Guidance for Industry Current Good Manufacturing Practice Interim Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act DRAFT GUIDANCE This guidance document is
1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.
Effective Training for Cell Therapy Laboratories. Diane Kadidlo MT(ASCP) University of Minnesota Molecular and Cellular Therapeutics Facility
Effective Training for Cell Therapy Laboratories Diane Kadidlo MT(ASCP) University of Minnesota Molecular and Cellular Therapeutics Facility Training Personnel Biggest resource of an organization Reflect
Risk Assessment: Biosafety Cabinet
Risk Assessment: Biosafety Cabinet Biosafety cabinets (BSCs) serve as primary containment devices for operations involving potential splashes, spills or aerosolization of hazardous biological materials.
USP <797> Cleanroom Design and Environmental Monitoring. Andrew King, USP <797> Specialist CETA Member RCCP-SC
USP Cleanroom Design and Environmental Monitoring Andrew King, USP Specialist CETA Member RCCP-SC Objectives The objectives of this presentation: To summarize basic cleanroom concepts and how
US Regulations for Import and Export of Cell Therapy Products
US Regulations for Import and Export of Cell Therapy Products Kurt Gunter, MD U Minnesota UCB Transplants (2001-2007)* Total units: 790 Number US banks: 19 Number non-us banks: 12 % units from non-us banks:
Contamination Control and Environmental Monitoring Systems
Life Science Contamination Control and Environmental Monitoring Systems Hospital Electronics Brookhaven Instruments deliver, install and validate particle counters, Microbial Air Samplers and Monitoring
Qualification of Cleanrooms and Environmental Monitoring - Practical Approaches in Europe
Qualification of Cleanrooms and Environmental Monitoring - Practical Approaches in Europe 1 Dr. Doris Herrmann Zum Eselsbachtal 20 67657 Kaiserslautern [email protected] www.gmp-unlimited.com
Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI
Risk-Based Environmental Monitoring Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Presenter Marsha Stabler Hardiman Over 20 years experience in the
11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07
In-process control In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07 Here you will find answers to the following questions: What are the in-process control tasks? Where
5th Edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration. Summary of Changes
5th Edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration Summary of Changes This document summarizes the changes made to the 5th edition of the
EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4
Ref. Ares(2015)283695-23/01/2015 PT CHAPTER 5 PRODUCTION EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy EudraLex
NSF Dietary Supplement
NSF Dietary Supplement SOP Template Book A guide to achieving and maintaining compliance to 21 CFR 111: Dietary Supplement Good Manufacturing Practices 2 Contents How to Use...4 About NSF Dietary Supplements...5
Validation of process gas systems
Validation of Process Gas Systems By Jeff Hargroves Alza Corporation Validation of process gas systems involve documenting the expected system behavior, and verifying that the system performs as expected.
Standard No.CEA/STL-036
Standard No. Page 1 Clinical Establishment Act Standard for Stem Cell Laboratory (Peripheral Blood Stem Cells and Umbilical Cord Cells) Standard No. Page 2 Introduction In 2010 Clinical Establishments
Cleanroom. For. Sterile Manufacturing Facilities
Cleanroom For Sterile Manufacturing Facilities Praphon Angtrakool Food and Drug Administration 1 WHO TRS No. 823 Annex 1, 1992 (1) General 17.1 The production of sterile preparations should be carried
VALIDATION AND QUALIFICATION
VALIDATION AND QUALIFICATION Lizette Caballero, B.S., M.T. (ASCP) Laboratory Manager Cellular Therapy Laboratory Florida Hospital Cancer Institute Orlando, FL 1 Learning Objectives Validation of Equipment
Corden Pharma Latina S.p.A. 5/20/16
Corden Pharma Latina S.p.A. 5/20/16 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 Via UPS Warning Letter 320-16-14 Return Receipt Requested
Cord Blood Banking and Biologic License Application (BLA) November 19, 2010
Cord Blood Banking and Biologic License Application (BLA) November 19, 2010 1 Webinar Presenters Tara Sadeghi, BS University of Texas MD Anderson Cord Blood Bank Michele Carbone, MS, CLS, MT(ASCP)SH,DLM,CQM,
JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS
JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS 1 WHAT IS A SITE MASTER FILE? A Site Master File (SMF) is a document prepared by the manufacturer containing specific
The use of risk assessment tools for microbiological assessment of cleanroom environments. by Tim Sandle
The use of risk assessment tools for microbiological assessment of cleanroom environments by Tim Sandle Email: [email protected] / [email protected] Web: www.pharmig.blogspot.com Environmental
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL
White paper: The 10 Golden Rules of GMP
White paper: The 10 Golden Rules of GMP The Good Manufacturing Practice regulations that govern pharmaceutical and medical device manufacturing can seem overwhelming. Use these ten golden rules to drive
Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant
Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human
Creating a cgmp Facility for Early Clinical Trials of Molecular Imaging and Therapeutic Agents
Designing for the Frontiers of Research Creating a cgmp Facility for Early Clinical Trials of Molecular Imaging and Therapeutic Agents Richard J. Mohr What if it were possible to treat a cancer patient
Validation and Calibration. Definitions and Terminology
Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an
Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1
Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and
Quality Assurance in Blood Cell Labelling
Quality Assurance in Blood Cell Labelling Sietske Rubow Radiopharmacist Nuclear Medicine Tygerberg Hospital and Stellenbosch University [email protected] Overview What is QA QA in Blood Cell Labelling Staff
CLASSIFICATION OF CLEANROOMS
CLASSIFICATION OF CLEANROOMS Cleanrooms are classified by the cleanliness of their air. The method most easily understood and most universally applied is the one suggested in the earlier versions (A to
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates 14 pharmacists and 1 epidemiologist make up the committee USP staff FDA and CDC representatives have input but do not vote Call for Candidates
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group [email protected]
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group [email protected] Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
Improvement in QC Environmental Monitoring Processes with Paperless Data Capture System
Improvement in QC Environmental Monitoring Processes with Paperless Data Capture System Presented by Susan Harrison Senior Manager, Microbiology Jeremy Tanner QC Information System Specialist Co-sponsors
Guidance for Industry
Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications Additional copies of this guidance are
Guidance for Industry
Guidance for Industry Biologics License Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients
Basic requirements for quality management in plant pest diagnosis laboratories
Blackwell Publishing Ltd European and Mediterranean Plant Protection Organization PM 7/84 Organisation Européenne et Méditerranéenne pour la Protection des Plantes Diagnostics Diagnostic Basic requirements
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. [email protected] Overview GMP requirements for Quality Control laboratories
Understanding USP 797
DDK Scientific, Corp. Raul Duarte June 2008 Copyright DDK Scientific, Corp. 2008, 2009 DDK Scientific, Corp. Proprietary The purpose of USP 797 is to prevent harm and fatality to patients that could result
Audit Report in the framework of the APIC Audit Programme
Audit Report in the framework of the APIC Audit Programme Company Location Address Country Subject of Audit Audit Date Auditor (lead) Co-Auditor(s) Participants Signature of Auditor(s) Lead Auditor Co-Auditor
Cord Blood Licensure. Session 2C: Advanced Cell Therapies April 11, 2013
Cord Blood Licensure Session 2C: Advanced Cell Therapies April 11, 2013 Objectives Describe rationale for cord blood licensure Cite licensure regulations Illustrate a case study of one program s pathway
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION
WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Working document QAS/03.055/Rev.2 RESTRICTED SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION This document has followed
Annex 4 Supplementary guidelines on good manufacturing practices: validation
World Health Organization WHO Technical Report Series, No. 937, 2006 Annex 4 Supplementary guidelines on good manufacturing practices: validation 1. Introduction 2. Scope 3. Glossary 4. Relationship between
Liquid II Cell Culture Media Manufacturing Plant. Overview Facilities Water for Injection Sterile Environment Media Handling Cleanroom Interior
Liquid II Cell Culture Media Manufacturing Plant Overview Facilities Water for Injection Sterile Environment Media Handling Cleanroom Interior Overview History of BioConcept and Amimed BioConcept has close
Sample Pharmacy CLEANING AND SANITIZING PROCEDURE P-304.1
P-304.1 1.0 Definition and Purpose: To standardize and define the process by which the controlled Cleanroom environments (ISO Class 5, 7, and 8) and the general pharmacy prep area is cleaned, disinfected,
Pharmaceutical Wholesaler Site Inspection Checklist
Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:
TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS
TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS APPLICATION NOTE CC-105 (US) Introduction This application note will demonstrate how real-time viable particle count data will
Luca Romagnoli, Ph.D. Business Development Manager
Modelli innovativi di produzione per lo sviluppo di un processo altamente qualitativo di farmaci biologici Luca Romagnoli, Ph.D. Business Development Manager BIOLOGICAL DRUGS - SOURCES Monoclonal antibodies
Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.
Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known
Procedures for the Effective Use of Biological Safety Cabinets
Procedures for the Effective Use of Biological Safety Cabinets APPROVAL DATE BY BIOHAZARDS SUBCOMMITTEE: August 10, 2012 SUPERSEDES: March 1, 2012 This corporate guideline/procedure is intended as a minimum
Sandoz Private Limited 10/22/15
Sandoz Private Limited 10/22/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 Warning Letter VIA UPS WL: 320-16-01 October 22, 2015
The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.
Supplier Quality Standard 1.0 Purpose The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. These expectations
Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA
Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels Master of Drug Regulatory Affairs
Air and Water Balancing - Sound and Vibration Testing - Cleanroom Services - Building Commissioning Building Envelope Testing Thermal Imaging
NEUDORFER ENGINEERS, INC. provides our customer with unbiased, professional, performance testing of Cleanrooms. We are committed to providing you, our customer, with value-added expertise in an effort
Quality Information. Buchs Manufacturing Site
Buchs Manufacturing Site Related Documents Buchs ISO 9001:2008 Certificate Buchs cgmp Certificate Buchs ISO 13485:2012 Certificate Buchs ISO 17025:2005/ ISO Guide 34 Certificate Buchs Management System
Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles
World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles Introduction 37 General considerations 39 Glossary
LIBRARY GUIDE. Online Courses. March 2012
LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................
CHAPTER 7 QUALITY ASSESSMENT
CHAPTER 7 QUALITY ASSESSMENT Chapter 7 QUALITY ASSESSMENT 7.1 OVERVIEW OF CBB-SPECIFIC QUALITY ASSURANCE/QUALITY CONTROL PROGRAM An extensive, site-specific Quality Assurance/Quality Control (QA/QC) program
Quality, GMPs & Food Safety Principles
Quality, GMPs & Food Safety Principles 1 Corporate Quality and Product Safety. Our Commitment As a global company, with production sites around the world, we commit ourselves to continuously improve our
Risk Based Environmental Monitoring (EM) and EM Data Management and Trending
Risk Based Environmental Monitoring (EM) and EM Data Management and Trending An Industry Roundtable Discussion Marsha Stabler Hardiman and Parsa Famili March 11, 2015 PDA NE Chapter Meeting Presenters
OPERATIONAL STANDARD
1 of 11 1. Introduction The International Safe Transit Association (ISTA), a non-profit association whose objective is to prevent product damage and excess packaging usage within the distribution environment.
2016 > Emcure Pharmaceuticals Limited 3/3/16
Seite 1 von 7 U.S. Food and Drug Administration Protecting and Promoting Your Health Emcure Pharmaceuticals Limited 3/3/16 Department of Health and Human Services Public Health Service Food and Drug Administration
Microbiology and Auditing. Don Singer
Microbiology and Auditing Don Singer ASQ Northeast Pharmaceutical GMP/Quality Conference 2011 Through the eyes of a Microbiologist Microbiology Audit = Inspection / Investigation Systematic Auditing Planning
REAL TIME LABORATORY MONITORING SYSTEM
REAL TIME LABORATORY MONITORING SYSTEM MONITORING LET XILTRIX WATCH OVER YOUR LABORATORY! 20 years experience and IKS expertise makes XiltriX the total monitoring solution for any laboratory. All day,
Identifying and Resolving GMP Issues for Pharmaceutical Process and Facility Design
IVTGXP_April07.qxd 3/19/07 12:59 PM Page 42 Identifying and Resolving GMP Issues for Pharmaceutical Process and Facility Design By The absolute, most important aspects of GMP are to remain in control of
Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations
Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
Particle Counting and Environmental Monitoring In Pharmaceutical / Life Sciences
Particle Counting and Environmental Monitoring In Pharmaceutical / Life Sciences LIGHTHOUSE WORLDWIDE SOLUTIONS WWW.GOLIGHTHOUSE.COM Introduction The pharmaceutical and medical device industries are developing
